Pages
    Products
    View All +
      No input value added to show the results.
      User
      User
      Get in Touch
      Order Online
      11 June 2025

      Wednesday, June 25, 2025 at 15:00 BST / 16:00 CEST / 10:00 EDT / 7:00 PDT 

      What's the webinar about?

      This webinar explores key aspects of hormonal diagnostics in female reproductive health, focusing on practical approaches to evaluating irregular cycles, diagnosing PCOS, and assessing ovarian reserve and menopause. It highlights the clinical use of key biomarkers such as AMH and FSH, and how hormonal testing supports decision-making in women’s health.

      The session also introduces Medix Biochemica’s hormone antibody and antigen portfolio, designed to support the development of reliable IVD solutions in reproductive diagnostics.

      It is intended for clinicians, gynecologists, endocrinologists, and IVD professionals involved in developing diagnostic solutions for women’s health.

      To sign up for our Webinar, simply click the link below

      Sign up for the Free Webinar

      Discussion points:  

      Hormonal Diagnostics in Women’s Health

      • Evaluation of irregular menstrual cycles
      • Hormonal measurements in PCOS diagnostics
      • AMH in PCOS diagnostics
      • How to measure gonadal function and ovarian reserve
      • Evaluation of menopause
      • Medix Biochemica’s hormone antibody and antigen portfolio for IVD test development

       

      Key take aways: 

      • Evaluation of irregular cycles is important to identify health impairments in women
      • The PCOS diagnostic algorithm includes serum measurements to evaluate hyperandrogenism and polycystic ovarian morphology
      • Ovarian reserve and menopausal status may be supported by serum AMH and FSH measurements
      • Medix Biochemica’s hormone antibodies and antigens support the development of reliable IVD tools for reproductive health diagnostics

      Contact us for more information!

      Get in Touch


      Our speakers and host for the webinar

      Terhi Piltonen
      Prof. Terhi Piltonen
      Professor of Obstetrics and Gynecology, University of Oulu, Finland
      Terhi Piltonen, MD, PhD, is a professor of Obstetrics and Gynecology at Oulu University, Finland. She leads a research team focused on polycystic ovary syndrome (PCOS), endometrial function, and hormonal contraceptives with translational approach utilizing national register data, birth cohorts, clinical trials and animal work. Prof. Piltonen is a past associate editor for European Journal of Endocrinology and Fertility and Sterility, Co-Editor in Chief of Seminars in Reproductive Medicine. Currently she is the president of the Androgen Excess and PCOS Society and scientific chair and board member of the Nordic Federation of Obstetrics and Gynecology (NFOG). She has published over 200 publications with an H-index of 51.
      LinkedIn
      Dr. Maria Voutilainen
      Dr. Maria Voutilainen
      Global Product Manager, Medix Biochemica
      Dr. Maria Voutilainen is the Global Product Manager at Medix Biochemica, where she oversees the Neurology, Hormones, Drugs of Abuse, Veterinary, and Therapeutic Drug Monitoring portfolios. In her current position, she is responsible for the strategic planning, development, and commercialization of these product lines, ensuring they meet the highest standards of quality and efficacy.Maria has extensive experience in the private bioscience sector. She has worked with laboratory instruments, consumables, and in vitro diagnostic (IVD) assays across various stages of the product life cycle, from initial research and development to market launch and post-market support. Maria holds a PhD in Genetics from the University of Helsinki. She is dedicated to science communication and promoting partnerships and dialogue between the private sector and academic institutions.
      LinkedIn
      Anthony Austin Profile Image Large
      Anthony Austin
      Global Marketing Manager, Medix Biochemica
      Anthony is the Global Marketing Manager for Medix Biochemica, starting in 2022. He enters this role after 15 years holding various science focused responsibilities in R&D, Manufacturing, Analytical and Product Management. Prior to Medix Biochemica, he worked in academic labs studying bone metabolism and genetic diseases affecting white blood cells and their ability to fight infections.
      LinkedIn